Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Mad Cow Disease Case Confirmed In California, USDA Says

Mad Cow Disease Case Confirmed In California, USDA Says

U.S. live cattle futures spiraled lower Tuesday afternoon, following news of a confirmed case of mad cow disease in central California.

As the Department of Agricultural held a press conference detailing the first case of mad cow disease since 2006, live cattle futures sank by the exchange limit across the board for 2012.

Cattle futures for June plunged 3 cents, or 2.6 percent, to settle at $1.11575 a pound on the Chicago Mercantile Exchange.

The price drop was said to be in response to the traveling news of mad cow disease and fund liquidation.

John Clifford, the USDA's chief veterinarian, told reporters Tuesday in a briefing in Washington that the animal was found at a rendering facility. The meat of the animal did not enter the food chain and the carcass will be destroyed, Clifford said. Milk from the cow was safe.

Mad cow disease was first discovered in December 2003 in an animal that came from Canada, and this marks the fourth confirmed case of the brain-wasting disease in the U.S. cattle herd.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.